Neomycin inhibits glioma cell migration
Related Experiment Video
Updated: Aug 24, 2026
Real-Time Monitoring of Human Glioma Cell Migration on Dorsal Root Ganglion Axon-Oligodendrocyte Co-Cultures
Published on: December 13, 2019
Pedro Cuevas1, Diana Díaz-González, Manuel Dujovny
1Departamento de Investigación, Hospital Universitario Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, Spain. pedro.cuevas@hrc.es
Abstract:
Blocking migration is an attractive strategy to inhibit glioma tumorigenesis. Previous studies have indicated that neomycin inhibits glioma cells proliferation. The purpose of this study was to expand on the preliminary research by investigating the antimigratory effect of neomycin. We used glioma C6 cells to investigate the role of neomycin in cell migration in vitro. Cell wounding assay showed that neomycin inhibits in a dose-dependent manner glioma cells migration into the wound. Taken together, these results suggest that neomycin is an attractive candidate for the development of novel antimigratory molecules useful for the treatment of gliomas.
Insights
Neomycin effectively inhibits glioma cell migration, suggesting its potential as a novel therapeutic agent for glioma treatment. This study investigated neomycin's antimigratory effects on C6 glioma cells in vitro.
Area of Science:
- Neuroscience
- Oncology
- Pharmacology
Background:
- Glioma tumorigenesis can be inhibited by blocking cell migration.
- Neomycin has demonstrated inhibitory effects on glioma cell proliferation in prior research.
Purpose of the Study:
- To investigate the antimigratory effect of neomycin on glioma cells.
- To expand on preliminary findings regarding neomycin's impact on glioma.
Main Methods:
- Utilized C6 glioma cells for in vitro studies.
- Performed a cell wounding assay to assess migration inhibition.
Main Results:
- Neomycin demonstrated a dose-dependent inhibition of glioma cell migration into the wounded area.
- The antimigratory effect was observed in vitro.
Conclusions:
- Neomycin exhibits significant antimigratory properties against glioma cells.
- Neomycin is a promising candidate for developing new antimigratory drugs for glioma treatment.
More Related Videos
08:35A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
Published on: July 20, 2017
09:17Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019